Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Preprandial Lispro more effective then postprandial Lispro
Postprandial Insulin Lispro May Impair Long-Term Glycemic Control
Preprandial Lispro more effective then postprandial Lispro
Administering insulin lispro postprandially appears to be a useful strategy for patients with an unpredictable eating schedule, although for continuous long-term use, the risk of poorer glycemic control may need to be considered.
Postprandial insulin administration allows adjustment of the insulin dose according to the calories actually ingested. Therefore, this may be a useful strategy for some patients with unpredictable schedules, such as children, frequent travelers, or those with decreased gastric emptying rate.
Guntram Schernthaner, MD, with the Department of Internal Medicine, at the Rudolfstitung Hospital, in Vienna, Austria, and colleagues conducted a 6-month, crossover study comparing the metabolic effects of routine use of preprandial versus postprandial injection of bolus insulin lispro.
Thirty-one patients with type 1 diabetes injected insulin lispro either preprandially or postprandially for a 3-month period. They then switched and to the alternate regimen for a further 3 months. The researchers measured glycosylated hemoglobin (HbA1c), fructosamine, and 8-point self-determined blood glucose profiles.
With preprandial insulin lispro, mean HbA1c decreased slightly from baseline whereas it increased slightly with postprandial administration, and this resulted in a significant difference in final HbA1c level (P = .008).
Mean fructosamine also decreased slightly with preprandial insulin lispro but was almost unchanged with postprandial insulin. Overall daily blood glucose was similar between the two treatments (P = .312). However, mean preprandial glucose was lower (P = .026), whereas mean postprandial glucose was higher (P = .031) with postprandial insulin lispro administration.
In addition, mean blood glucose excursions were higher with postprandial compared with preprandial insulin lispro, indicating greater daily fluctuations. No difference in incidence of hypoglycemia was observed with the two treatment regimens, however.
The researchers conclude that postprandial administration of insulin lispro “appears to be an acceptable treatment regimen since it adequately controls blood glucose.”
However, they point out that “the daily fluctuations appear to be increased and this could result in increasing HbA1c levels with continuous postprandial administration for long periods. Therefore, HbA1c should continue to be monitored and the benefits of postprandial administration may have to be balanced against less beneficial glycemic control,” they suggest.
Diabet Med 2004 Mar;21:3:279-84
The First Step Program© is now available in the U.S. The only walking program that has gone through clinical studies and has been published in scientific journals showing its effectiveness in increasing physical activity. Start the New Year by taking the First Step to better health for your patients. www.firststepprogram.com Then go to www.firststeptracker.com and have access to your patients steps/day information.